Press
Press & News
Announcements, press releases, and organizational milestones from Amavita Research.
Recent press releases and news announcements from Amavita Research. For media inquiries, contact julio@amavita.health.
2026 Announcements
13 May 2026
Coronary stent procedures at the affiliated cardiovascular ASC in Miami-Dade
Amavita Research performs a coronary stent procedure at the affiliated Kendall ASC (Advanced Cardiovascular of Miami) — a dedicated cardiovascular ambulatory surgery center (ASC) in Miami-Dade, with same-day discharge — led by Dr. Pedro Martinez-Clark.
13 May 2026
Amavita Research Is GCSA-Recertified (May 13, 2026)
Independent assessment confirms continued operational excellence across all 7 modules of the GCSA V5 2024 standard. GCSA-certified (recertified May 13, 2026, valid to Feb 28, 2027).
Media contact
- For media inquiries: julio@amavita.health
- Phone: (954) 903-7210
- Address: 100 NW 170 St, Suite 305, North Miami Beach, FL 33169, USA
About Amavita Research
Amavita Research Services, LLC is a Miami-based cardiovascular clinical research site founded in 2017, operating inside amavita Heart and Vascular Health® — independent Miami cardiovascular practice; 16,000+ patients seen in the last 3 years. IAOCR GCSA-certified (recertified May 13, 2026, valid to Feb 28, 2027). Sister organization to bioaccess®, the Americas first-in-human CRO. Site capabilities: https://www.amavitaresearch.com/capabilities. Trial services: https://www.amavitaresearch.com/trial-services.